REPORTS

Let’s Pullulate and Expand Your Business

Zika Virus Vaccine Market - Global Professional Analysis and Forecast to 2026

Oct 21, 2019  |  175 PAGES  |  REPORT CODE: CMM219881
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Zika Virus Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 2.4% during the forecast period.

This report presents the market size and development trends by detailing the Zika Virus Vaccine market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Zika Virus Vaccine market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Zika Virus Vaccine industry and will help you to build a panoramic view of the industrial development.

Zika Virus Vaccine Market, By Type:

  • DNA Vaccine

  • Inactivated Vaccine

  • Purified Inactivated Vaccine

Zika Virus Vaccine Market, By Application:

  • Hospital

  • Medical Research

  • Others

Some of the leading players are as follows:

  • Intrexon Corp.

  • Takeda

  • GeneOne Life Science Inc

  • NewLink Genetics Corp.

  • PaxVax

  • Gilead Sciences Inc.

  • NHI

  • Inovio Pharmaceuticals

  • Sanofi

  • Bharat.

  • Immunovaccine Inc.

  • GSK

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Zika Virus Vaccine Market: Technology Type Analysis

  • 4.1 Zika Virus Vaccine Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Zika Virus Vaccine Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 DNA Vaccine

    • 4.3.2 Inactivated Vaccine

    • 4.3.3 Purified Inactivated Vaccine

5 Zika Virus Vaccine Market: Product Analysis

  • 5.1 Zika Virus Vaccine Product Market Share Analysis, 2018 & 2026

  • 5.2 Zika Virus Vaccine Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Zika Virus Vaccine Market: Application Analysis

  • 6.1 Zika Virus Vaccine Application Market Share Analysis, 2018 & 2026

  • 6.2 Zika Virus Vaccine Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hospital

    • 6.3.2 Medical Research

    • 6.3.3 Others

7 Zika Virus Vaccine Market: Regional Analysis

  • 7.1 Zika Virus Vaccine Regional Market Share Analysis, 2018 & 2026

  • 7.2 Zika Virus Vaccine Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Intrexon Corp.

    • 9.1.1 Intrexon Corp. Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Takeda

    • 9.2.1 Takeda Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 GeneOne Life Science Inc

    • 9.3.1 GeneOne Life Science Inc Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 NewLink Genetics Corp.

    • 9.4.1 NewLink Genetics Corp. Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 PaxVax

    • 9.5.1 PaxVax Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Gilead Sciences Inc.

    • 9.6.1 Gilead Sciences Inc. Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 NHI

    • 9.7.1 NHI Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Inovio Pharmaceuticals

    • 9.8.1 Inovio Pharmaceuticals Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Sanofi

    • 9.9.1 Sanofi Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Bharat.

    • 9.10.1 Bharat. Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Immunovaccine Inc.

    • 9.11.1 Immunovaccine Inc. Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 GSK

    • 9.12.1 GSK Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

 

The List of Tables and Figures (Totals 111 Figures and 134 Tables)

  • Figure DNA Vaccine Zika Virus Vaccine market, 2015 - 2026 (USD Million)

  • Figure Inactivated Vaccine Zika Virus Vaccine market, 2015 - 2026 (USD Million)

  • Figure Purified Inactivated Vaccine Zika Virus Vaccine market, 2015 - 2026 (USD Million)

  • Figure Hospital market, 2015 - 2026 (USD Million)

  • Figure Medical Research market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Zika Virus Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table North America Zika Virus Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table North America Zika Virus Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table North America Zika Virus Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Zika Virus Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Zika Virus Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Zika Virus Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Zika Virus Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Canada Zika Virus Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Canada Zika Virus Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Europe Zika Virus Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table Europe Zika Virus Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Europe Zika Virus Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Europe Zika Virus Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Zika Virus Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Zika Virus Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Zika Virus Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Zika Virus Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Germany Zika Virus Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Germany Zika Virus Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Zika Virus Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table France Zika Virus Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table France Zika Virus Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Zika Virus Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Italy Zika Virus Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Italy Zika Virus Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Zika Virus Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Spain Zika Virus Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Spain Zika Virus Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Zika Virus Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Zika Virus Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Zika Virus Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Zika Virus Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Zika Virus Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table China Zika Virus Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table China Zika Virus Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Zika Virus Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Japan Zika Virus Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Japan Zika Virus Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Zika Virus Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table India Zika Virus Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table India Zika Virus Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Zika Virus Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Zika Virus Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Zika Virus Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Zika Virus Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Zika Virus Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Zika Virus Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Zika Virus Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Zika Virus Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Zika Virus Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Zika Virus Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Zika Virus Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Zika Virus Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Zika Virus Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table MEA Zika Virus Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table MEA Zika Virus Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table MEA Zika Virus Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table MEA Zika Virus Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Zika Virus Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Zika Virus Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Zika Virus Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Zika Virus Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Zika Virus Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Zika Virus Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Intrexon Corp. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Takeda Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GeneOne Life Science Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table NewLink Genetics Corp. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table PaxVax Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Gilead Sciences Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table NHI Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Inovio Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bharat. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Immunovaccine Inc. Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GSK Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top